High Throughput Screening Market to Reach USD 69.46 Billion by 2032, Growing at a CAGR of 12.18%
The High Throughput Screening (HTS) Market was valued at USD 25.80 billion in 2023 and is projected to reach USD 69.46 billion by 2032, growing at a CAGR of 12.18% from 2024 to 2032. HTS plays a pivotal role in accelerating drug discovery by enabling rapid screening of large chemical and biological libraries. Driven by increasing R&D investments, technological advancements in automation, miniaturization, and data analysis, the market is witnessing substantial growth. The expanding use of HTS in pharmaceutical, biotechnology sectors, and academic research centers is further fuelling demand.